Value-Based Care and Innovation-Driven Pharma Webinar

by

About this Webinar

This webinar highlighted that VBC presents both opportunities and risks for innovation-driven pharmaceutical organizations who are either wading or diving head first into the digital health space.

Key Takeaways:

  • Pharma can leverage VBCs to differentiate and demonstrate the effectiveness of their beyond-the-pill initiatives versus their competitors, which can assist payers in making formulary and other reimbursement decisions
  • Payers can utilize VBCs to gain experience with a beyond-the-pill solution or program, reducing uncertainty regarding clinical value, performance, and financial impact
  • Overview of the 6P stakeholders of VBCs
  • How digital health, digital medicine, and DTx are ripe for VBC reimbursement models
  • The importance of VBC to the industry – VBCs align stakeholders to achieve performance goals and collaborate on the delivery of these goals 
  • However, there are new workstreams, data sharing agreements, and infrastructure that may be required to successfully implement a VBC arrangement between parties


About the Host

Tai Chung –  Director of Partnerships

Tai is a senior leadership team member who focuses on digital health commercialization and clinical trials. He currently leads partnerships for clinical and engagement platforms and software as a service (SaaS) solutions. Tai assists clients with value-based care arrangements/contracting and the commercialization of digital care, health, medicine, therapeutic (DTx), and software as a medical device (SaMD) solutions. In his role, he leverages 15+ years of finance, legal, compliance, and healthcare experience to influence c-level executives and engagements. 

Contact Us

We’re Here To Help

Whether you’re ready to talk to someone right now or just want general information

Global HQ

240 Elm St., 2nd Floor Somerville, MA 02144

Phone

+1-617-547-0273